These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

169 related articles for article (PubMed ID: 34959310)

  • 21. A novel pleuromutilin antibacterial compound, its binding mode and selectivity mechanism.
    Eyal Z; Matzov D; Krupkin M; Paukner S; Riedl R; Rozenberg H; Zimmerman E; Bashan A; Yonath A
    Sci Rep; 2016 Dec; 6():39004. PubMed ID: 27958389
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Antibacterial Activity and Structure-Activity Relationship of a Series of Newly Synthesized Pleuromutilin Derivatives.
    Li YG; Wang JX; Zhang GN; Zhu M; You XF; Hu XX; Zhang F; Wang YC
    Chem Biodivers; 2019 Feb; 16(2):e1800560. PubMed ID: 30467968
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Introduction: lefamulin and pharmacokinetic/pharmacodynamic rationale to support the dose selection of lefamulin.
    Rodvold KA
    J Antimicrob Chemother; 2019 Apr; 74(Suppl 3):iii2-iii4. PubMed ID: 30949709
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Design, synthesis, and antibacterial activity of novel pleuromutilin derivatives bearing an amino thiazolyl ring.
    Ling Y; Wang X; Wang H; Yu J; Tang J; Wang D; Chen G; Huang J; Li Y; Zheng H
    Arch Pharm (Weinheim); 2012 Aug; 345(8):638-46. PubMed ID: 22532317
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Efficacy and Safety of Intravenous-to-oral Lefamulin, a Pleuromutilin Antibiotic, for the Treatment of Community-acquired Bacterial Pneumonia: The Phase III Lefamulin Evaluation Against Pneumonia (LEAP 1) Trial.
    File TM; Goldberg L; Das A; Sweeney C; Saviski J; Gelone SP; Seltzer E; Paukner S; Wicha WW; Talbot GH; Gasink LB
    Clin Infect Dis; 2019 Nov; 69(11):1856-1867. PubMed ID: 30722059
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Lefamulin: a promising new pleuromutilin antibiotic in the pipeline.
    Dillon C; Guarascio AJ; Covvey JR
    Expert Rev Anti Infect Ther; 2019 Jan; 17(1):5-15. PubMed ID: 30513017
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Leave it to Lefamulin: A Pleuromutilin Treatment Option in Community-Acquired Bacterial Pneumonia.
    Lee YR; Jacobs KL
    Drugs; 2019 Nov; 79(17):1867-1876. PubMed ID: 31705486
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Biosynthesis of pleuromutilin congeners using an
    Alberti F; Khairudin K; Davies JA; Sangmalee S; Willis CL; Foster GD; Bailey AM
    Chem Sci; 2023 Apr; 14(14):3826-3833. PubMed ID: 37035691
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Novel pleuromutilin derivatives as antibacterial agents: synthesis, biological evaluation and molecular docking studies.
    Wang X; Ling Y; Wang H; Yu J; Tang J; Zheng H; Zhao X; Wang D; Chen G; Qiu W; Tao J
    Bioorg Med Chem Lett; 2012 Oct; 22(19):6166-72. PubMed ID: 22932314
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Assessing Boron-Pleuromutilin AN11251 for the Development of Antibacterial Agents.
    Han MJ; Pan M; Xiao G; Yuan Y; Chen S; Zou Z
    Molecules; 2023 Jun; 28(12):. PubMed ID: 37375183
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Heterologous expression reveals the biosynthesis of the antibiotic pleuromutilin and generates bioactive semi-synthetic derivatives.
    Alberti F; Khairudin K; Venegas ER; Davies JA; Hayes PM; Willis CL; Bailey AM; Foster GD
    Nat Commun; 2017 Nov; 8(1):1831. PubMed ID: 29184068
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Development of a Modular Synthetic Route to (+)-Pleuromutilin, (+)-12-epi-Mutilins, and Related Structures.
    Zeng M; Murphy SK; Herzon SB
    J Am Chem Soc; 2017 Nov; 139(45):16377-16388. PubMed ID: 29048164
    [TBL] [Abstract][Full Text] [Related]  

  • 33.
    Paukner S; Gruss A; Jensen JS
    Antimicrob Agents Chemother; 2018 May; 62(5):. PubMed ID: 29530863
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Interaction of pleuromutilin derivatives with the ribosomal peptidyl transferase center.
    Long KS; Hansen LH; Jakobsen L; Vester B
    Antimicrob Agents Chemother; 2006 Apr; 50(4):1458-62. PubMed ID: 16569865
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Synthesis, biological activities, and docking study of novel chalcone-pleuromutilin derivatives.
    Xie C; Zhang S; Zhang W; Wu C; Yong C; Sun Y; Zeng Z; Zhang Q; Huang Z; Chen T; Zhang Y
    Chem Biol Drug Des; 2020 Aug; 96(2):836-849. PubMed ID: 32271987
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Biosynthetic Machinery of Diterpene Pleuromutilin Isolated from Basidiomycete Fungi.
    Yamane M; Minami A; Liu C; Ozaki T; Takeuchi I; Tsukagoshi T; Tokiwano T; Gomi K; Oikawa H
    Chembiochem; 2017 Dec; 18(23):2317-2322. PubMed ID: 28924980
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Lefamulin: a New Hope in the Field of Community-Acquired Bacterial Pneumonia.
    Adhikary S; Duggal MK; Nagendran S; Chintamaneni M; Tuli HS; Kaur G
    Curr Pharmacol Rep; 2022; 8(6):418-426. PubMed ID: 35811574
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Total synthesis of structurally diverse pleuromutilin antibiotics.
    Goethe O; DiBello M; Herzon SB
    Nat Chem; 2022 Nov; 14(11):1270-1277. PubMed ID: 36163267
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Synthesis, biological activities and docking studies of pleuromutilin derivatives with piperazinyl urea linkage.
    Zhang Y; Xie C; Liu Y; Shang F; Shao R; Yu J; Wu C; Yao X; Liu D; Wang Z
    J Enzyme Inhib Med Chem; 2021 Dec; 36(1):764-775. PubMed ID: 33733986
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Antibacterial properties and clinical potential of pleuromutilins.
    Goethe O; Heuer A; Ma X; Wang Z; Herzon SB
    Nat Prod Rep; 2019 Jan; 36(1):220-247. PubMed ID: 29979463
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.